Literature DB >> 32369830

Quality performance and associated factors in Swiss diabetes care - A cross-sectional study.

Rahel Meier1, Fabio Valeri1, Oliver Senn1, Thomas Rosemann1, Corinne Chmiel1.   

Abstract

INTRODUCTION: Quality indicators and pay-for-performance schemes aim to improve processes and outcomes in clinical practice. However, general practitioner and patient characteristics influence quality indicator performance. In Switzerland, no data on the pay-for-performance approach exists and the use of quality indicators has been marginal. The aim of this study was to describe quality indicator performance in diabetes care in Swiss primary care and to analyze associations of practice, general practitioner and patient covariates with quality indicator performance.
METHODS: For this cross-sectional study, we used medical routine data from an electronic medical record database. Data from 71 general practitioners and all their patients with diabetes were included. Starting in July 2018, we retrieved 12-month retrospective data about practice, general practitioner and patient characteristics, laboratory values, comorbidities and co-medication. Based on this data, we assessed quality indicator performance of process and intermediate outcomes for glycated hemoglobin, blood pressure, cholesterol and associations of practice, general practitioner and patient characteristics with individual and cumulative quality indicator performance. We calculated odds ratios (OR) and 95% confidence intervals (CI) using regression methods.
RESULTS: We assessed 3,383 patients with diabetes (57% male, mean age 68.3 years). On average, patients fulfilled 3.56 (standard deviation: 1.89) quality indicators, whereas 17.2% of the patients fulfilled all six quality indicators. On practice and general practitioner level, we found no associations with cumulative quality indicator performance. On patient level, gender (ref = male) (OR: 0.83, CI: 0.78-0.88), number of treating general practitioners (OR: 0.94, CI: 0.91-0.97), number of comorbidities (OR: 1.43, CI: 1.38-1.47) and number of consultations (OR: 1.02, CI: 1.02-1.02) were associated with cumulative quality indicator performance.
CONCLUSION: The influence of practice, general practitioner and patient characteristics on quality indicator performance was surprisingly small and room for improvement in quality indicator performance of Swiss general practitioners seems to exist in diabetes care.

Entities:  

Year:  2020        PMID: 32369830     DOI: 10.1371/journal.pone.0232686

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  5 in total

1.  Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review.

Authors:  Marit de Jong; Sanne A E Peters; Rianneke de Ritter; Carla J H van der Kallen; Simone J S Sep; Mark Woodward; Coen D A Stehouwer; Michiel L Bots; Rimke C Vos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-30       Impact factor: 6.055

2.  Ambulatory Healthcare Use Profiles of Patients With Diabetes and Their Association With Quality of Care: A Cross-Sectional Study.

Authors:  Julien Dupraz; Emilie Zuercher; Patrick Taffé; Isabelle Peytremann-Bridevaux
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

3.  Process quality of type 2 diabetes mellitus care and association with patient perceived attributes of family doctor service in urban general practices, Beijing, China.

Authors:  Guanghui Jin; Xiaoqin Lu; Feiyue Wang; Yun Wei; Meirong Wang; Zhaolu Pan
Journal:  BMC Prim Care       Date:  2022-09-07

4.  Continuity of care in patients with type 2 diabetes in Croatian primary care setting during COVID-19 pandemic: A retrospective observational study.

Authors:  Juraj Jug; Ivančica Peček; Stela Bukvić; Marija Petrovčić; Filip Bosnić; Ana Rukavina; Stanislava Stojanović Špehar
Journal:  Prim Care Diabetes       Date:  2022-09-28       Impact factor: 2.567

5.  The Effect of Financial Incentives on Quality Measures in the Treatment of Diabetes Mellitus: a Randomized Controlled Trial.

Authors:  Rahel Meier; Corinne Chmiel; Fabio Valeri; Leander Muheim; Oliver Senn; Thomas Rosemann
Journal:  J Gen Intern Med       Date:  2021-04-26       Impact factor: 5.128

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.